Results 291 to 300 of about 19,887 (300)

Direct-Acting Antivirals in Hepatitis C Virus-Associated Diffuse Large B-cell Lymphomas

Oncologist, 2019
Michele Merli, Marco Frigeni, Laurent Alric   +2 more
exaly  

Direct-acting antiviral therapy in sub-Saharan Africa

The Lancet Gastroenterology & Hepatology, 2019
C Wendy, Spearman, Mark W, Sonderup
openaire   +2 more sources

Hepatitis C and direct-acting antivirals

Hot Topics in Viral Hepatitis, 2013
openaire   +1 more source

Warfarin: interaction with direct-acting antivirals

Reactions Weekly, 2016
openaire   +1 more source

Outcomes, costs and cost–effectiveness of treating hepatitis C with direct acting antivirals

Journal of Comparative Effectiveness Research, 2015
Jona T Stahmeyer, Siegbert Rossol, Christian Krauth   +2 more
exaly  

Factors Associated With Increased Risk of De Novo or Recurrent Hepatocellular Carcinoma in Patients With Cirrhosis Treated With Direct-Acting Antivirals for HCV Infection

Clinical Gastroenterology and Hepatology, 2019
Elisabetta Degasperi, Roberta D’Ambrosio, Massimo Iavarone   +2 more
exaly  

Optimal therapy of HIV/HCV co‐infected patients with direct acting antivirals

Liver International, 2015
exaly  

Patient-reported outcomes with direct-acting antivirals for the treatment of chronic hepatitis C: current knowledge and outstanding issues

Expert Review of Gastroenterology and Hepatology
Fabienne Marcellin, Perrine Roux, Camelia Protopopescu   +2 more
exaly  

Direct-acting antivirals safe in elderly patients

Reactions Weekly, 2016
openaire   +1 more source

Tacrolimus/unspecified direct acting antivirals interaction

Reactions Weekly, 2018
openaire   +1 more source